SK Life Science, Inc. will present multiple posters at the American Academy of Neurology Annual Meeting, taking place April 18-22, 2026, in Chicago, Illinois. The presentations highlight clinical and real-world evidence related to cenobamate, an antiseizure medication, as well as new insights into the experiences and perspectives of people living with epilepsy and their healthcare providers.
SK Life Science is presenting multiple analyses related to cenobamate across clinical, real-world, and pharmacokinetic settings. These include healthcare utilization studies evaluating epilepsy-related and all-cause healthcare resource use following cenobamate initiation, analyses assessing the impact of achieving zero seizures on healthcare utilization, clinical data in adults and adolescents including primary generalized tonic-clonic seizures, population analyses evaluating drug exposure in adult and elderly patients, research on delayed or deferred epilepsy surgery in people with drug-resistant focal epilepsy, and open-label extension results in multinational patient populations.
Among the presentations is a new methodological analysis from the “Hope, Hesitancy, and Hard Truths” survey, which explores how patients and providers communicate about epilepsy treatment and seizure control. Initial findings from the survey were shared during National Epilepsy Awareness Month in November 2025. Survey respondents include people living with epilepsy and healthcare providers across multiple specialties, including neurologists, epileptologists, and advanced practice providers. According to the source material, approximately 3.4 million people in the United States are living with epilepsy, with approximately 150,000 new cases diagnosed each year. Nearly 40% of people with epilepsy do not achieve seizure freedom despite available treatments.
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://www.prnewswire.com/news-releases/sk-life-science-inc-to-present-new-data-and-epilepsy-insights-at-the-2026-american-academy-of-neurology-annual-meeting-302733025.html